1 asset in Attenuated Familial Adenomatous Polyposis

Therapeutic assets addressing Attenuated Familial Adenomatous Polyposis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Obeticholic Acid Attenuated Familial Adenomatous Polyposis	National Cancer Institute (NCI)	P2	CCC (53)